Vertex Announces Collaboration with Parion Sciences to Develop ENaC Inhitibors in CF, Pulmonary Dise
Vertex Announces Collaboration with Parion Sciences to Develop ENaC Inhitibors in CF, Pulmonary Diseases
The Highest Paid CEOs in Biotech
These highest paid CEOs in biotech brought in a minimum of $24 million in compensation in 2014. Find out what makes these leaders so special, and whether or not their exorbitant pay packages are sustainable.
3 Types of Risks Facing Biotech Stocks
Biotech stocks have been dramatically outperforming the broader market, but that doesn't mean they're free of risk. Here are three types of risks all biotech stocks face.
Could This Tiny Biotech Be on Gilead Sciences’ M&A Radar?
Gilead Sciences is on the the prowl for potential buyout targets. This little-known immuno-therapy company looks like a perfect match for the biotech in many ways. Here's why.